SCTX

SCTX P/E Ratio
P/E Ratio as of Nov 19, 2026: -5.74
Average-6.34
Median-6.38
Minimum-6.84
Maximum-5.74
-5.74
0.93 (13.94%)past month
The P/E ratio for SCTX is -5.74 as of Nov 19, 2026. This represents a increase of 925.00% compared to its 12-month average P/E ratio of -0.56. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Scribe Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Scribe Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Scribe Therapeutics Inc to industry peers.
Scribe Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Scribe Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Scribe Therapeutics Inc to industry peers.
SCTX P/E Ratio Insights
See Scribe Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in SCTX
Order type
Buy in
Order amount
Est. shares
0 shares
SCTX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 16, 2026 | $15.37 | -6.67 |
SCTX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -5.74 | — |
FAQs About Scribe Therapeutics Inc (SCTX) P/E ratio
The latest P/E ratio of SCTX is -5.74, as of Nov 19, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Scribe Therapeutics Inc’s last 12-month average P/E ratio is -0.56, compared to its current P/E ratio of -5.74. This reflects a increase of 925.00%.
Scribe Therapeutics Inc’s current P/E ratio of -5.74 is higher than its last 12-month average P/E of -0.56. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Scribe Therapeutics Inc’s average P/E ratio over the last 3 years is -0.19. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Scribe Therapeutics Inc’s average P/E ratio over the last 5 years is -0.11. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
SCTX P/E Ratio Insights
See Scribe Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in SCTX
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.